Wintachai Phitchayapak, Voravuthikunchai Supayang Piyawan
School of Science, Walailak University, Nakhon Si Thammarat 80161, Thailand.
Center of Antimicrobial Biomaterial Innovation-Southeast Asia and Natural Product Research Center of Excellence, Faculty of Science, Prince of Songkla University, Songkhla 90110, Thailand.
Pharmaceuticals (Basel). 2022 Feb 26;15(3):291. doi: 10.3390/ph15030291.
Multidrug-resistant (MDR) strains of have become a major cause of hospital-acquired infections, resulting in an increase in morbidity and mortality worldwide. Many alternative treatments, including phage therapy, are attractive approaches for overcoming problems posed by antibiotic resistance. A newly isolated phage, vWUPSU-specific MDR , showed a narrow host range against MDR . This research was conducted to isolate, characterize, and apply the phage with sacha inchi oil as an alternative antimicrobial agent. Genome analysis suggested that phage vWUPSU is a novel phage belonging to the family , order . This phage prevented biofilm formation and eradicated preformed biofilms in a dose-dependent manner. In addition, a synergistic antimicrobial effect of the interaction between phage vWUPSU and sacha inchi oil on planktonic cells was observed. The combination of phage and sacha inchi oil significantly inhibited and removed biofilms, compared with the effects of either single treatment. The results of this work indicate that phage vWUPSU could potentially be applied to control MDR The antibacterial and antibiofilm activities of the combination of phage vWUPSU and sacha inchi oil have attracted significant interests in the development of antibacterial phage products as beneficial treatment options.
多药耐药(MDR)菌株已成为医院获得性感染的主要原因,导致全球发病率和死亡率上升。许多替代治疗方法,包括噬菌体疗法,是克服抗生素耐药性问题的有吸引力的方法。一种新分离的噬菌体,vWUPSU特异性MDR,对MDR显示出狭窄的宿主范围。本研究旨在分离、表征并应用以印加果油作为替代抗菌剂的噬菌体。基因组分析表明噬菌体vWUPSU是一种属于科、目的新型噬菌体。该噬菌体以剂量依赖的方式阻止生物膜形成并根除预先形成的生物膜。此外,观察到噬菌体vWUPSU与印加果油之间相互作用对浮游细胞具有协同抗菌作用。与单一处理的效果相比,噬菌体和印加果油的组合显著抑制并去除生物膜。这项工作的结果表明噬菌体vWUPSU有可能用于控制MDR。噬菌体vWUPSU与印加果油组合的抗菌和抗生物膜活性在开发作为有益治疗选择的抗菌噬菌体产品方面引起了极大兴趣。